7:15 am - 9:00 am
Laura Borgelt, PharmD, FCCP, BCPS
Medical marijuana continues to be a hot topic in the U.S. This session will review regulatory issues for use of medical marijuana in the U.S., dosage forms and pharmacodynamic impact, potential therapeutic effects, potential drug interactions, and consumer safety issues.
9:15 am - 10:30 am
Concurrent Sessions (311-314)
Hospital Readmission in ESRD Patients: Challenges and Opportunities in Care
Amber Paulus, BSN, RN, CPHQ
Using dialysis facility reports and ESRD Quality Incentive Program data, this session will explore factors that influence hospital readmissions for ESRD patients as well as quality measures to reduce readmissions, including care coordination interventions.
What Would You Do if You Were Diagnosed with CKD?
Emaad Abdel-Rahman, MD
What would you do if you were diagnosed with kidney disease? One patient will share his journey from diagnosis with kidney disease to treatment with home hemodialysis to kidney transplant.
Cannulating a Dialysis Vascular Access: Using the ASSURE Model and Gagne’s Nine Events of Instruction
Pandora Goode, PhD, DNP, FNP-C, CNE
This session will focus on teaching dialysis concepts to patients. Cannulation of a vascular access will serve as an example to demonstrate instructional tools such as the ASSURE model and Gagne’s nine events of instruction.
Pathophysiologic Changes in Renal Disease
Alexis Harris Snead, MD
Ideal for the advanced practice nurse, this session will feature case studies focusing on the pathophysiologic changes that occur in various renal diseases as well as the implications for patient assessment and plan of care.
10:45 am - 12:00 nn
Concurrent Sessions (321-324)
Successful Transportation Models for Patients Requiring In-Center Dialysis Treatment and Training
Tamara Kear, PhD, RN, CNS, CNN
Seri Park, PhD, PTP
Current and projected statistics related to the number of people living with CKD will set the stage for a discussion of the impact that transportation has on access to care, adequacy of treatment, and treatment delivery options for patients with CKD.
Liver-Kidney Disease: Nursing Care Considerations
Brendan Bowman, MD
This session will address the pathophysiology, assessment, and treatment of liver-kidney disease, including hemodialysis, continuous renal replacement therapy, peritoneovenous shunt, etc. Patient care in both ICU and non-ICU care settings also will be covered.
Pediatric CKD Care: Not Little Adults
Keisha Gibson, MD, MPN
The demographics of children with CKD, special care considerations in pediatric patients with CKD, as well as the challenges of transitioning children to adult care settings will be discussed.
Bone Metabolism: New KDIGO Guidelines
Theresa Payne, DNP, APRN, FNP-C, CCRN-R
The 2017 KDIGO CKD-Mineral and Bone Disorder Clinical Practice Guideline will provide the foundation for this session focusing on the updated recommendations for the diagnosis, evaluation, and treatment of bone abnormalities in patients with CKD.
National Symposium adjourns